Alnylam Pharmaceuticals (ALNY) Convertible Debt (2022 - 2026)
Alnylam Pharmaceuticals (ALNY) recorded Convertible Debt of $1.01 billion in Q2 2026, down 1.5% from $1.03 billion a year earlier but up 0.2% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Convertible Debt (2022 - 2026) Analysis & Trends
Starting with Q3 2022, Alnylam Pharmaceuticals' Convertible Debt history includes 16 quarters.
- Annual Convertible Debt has a three-year compound annual growth rate of -0.3% (FY2022 to FY2025).
- Across earlier years, Convertible Debt came in at $1.02 billion in FY2024 (+0.4%), $1.02 billion in FY2023 (+0.4%) and $1.02 billion in FY2022.
- Quarterly Convertible Debt has ranged from $1.01 billion in Q4 2025 to $1.04 billion in Q3 2025 over the past five years.
- On a year-over-year basis, Convertible Debt has declined for three consecutive quarters, with an average decline of 0.2% over the last eight quarters.
- Peak year-over-year performance for Convertible Debt in the last five years was growth of 1.6% in Q3 2025, against a decline of 1.6% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.01 billion (Q1 2026), $1.01 billion (Q4 2025) and $1.04 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Bn |
| Mar 31, 2026 | 1.01 Bn |
| Dec 31, 2025 | 1.01 Bn |
| Sep 30, 2025 | 1.04 Bn |
| Jun 30, 2025 | 1.03 Bn |
| Mar 31, 2025 | 1.03 Bn |
| Dec 31, 2024 | 1.02 Bn |
| Sep 30, 2024 | 1.02 Bn |
| Jun 30, 2024 | 1.02 Bn |
| Mar 31, 2024 | 1.02 Bn |
| Dec 31, 2023 | 1.02 Bn |
| Sep 30, 2023 | 1.02 Bn |
| Jun 30, 2023 | 1.02 Bn |
| Mar 31, 2023 | 1.02 Bn |
| Dec 31, 2022 | 1.02 Bn |
| Sep 30, 2022 | 1.02 Bn |
API Access
Alnylam Pharmaceuticals Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();